8-K: Strive Acquires Semler Scientific in All-Stock Bitcoin Merger

Strive, Inc. announced an all-stock acquisition of Semler Scientific, Inc., creating a combined entity with over 10,900 Bitcoin and a focus on preventative diagnostics.

Summary

• Strive, Inc. has entered into a definitive agreement to acquire Semler Scientific, Inc. in an all-stock transaction.
• The deal represents an approximately 210% premium for Semler Scientific shareholders, equivalent to approximately $90.52 per share, based on market close on September 19, 2025.
• Each common share of Semler Scientific will be exchanged for 21.05 Class A common shares of Strive.
• Strive also announced the purchase of 5,816 Bitcoin for its corporate treasury at an average price of $116,047 per Bitcoin, totaling $675,000,000, bringing Strive's total Bitcoin holdings to 5,886.
• The combined company is projected to own over 10,900 Bitcoin prior to any additional Bitcoin raised from future financings.
• The combined company intends to explore monetizing or distributing Semler Scientific's historically profitable diagnostics business at a future date, with a new management team and expanded mandate in preventative diagnostics.
• The transaction has been unanimously approved by the boards of directors of both Strive and Semler Scientific and is subject to customary closing conditions.

Sentiment

Score: 8

Explanation: The filing announces a strategic merger with a significant premium for the acquired company's shareholders, substantial Bitcoin holdings, and a clear growth strategy. While risks are acknowledged, the overall tone and projected benefits are highly positive for both companies' stakeholders.

Positives

• The merger creates a scaled Bitcoin acquisition platform, positioning the combined company as a top Bitcoin treasury holder.
• Semler Scientific shareholders receive a substantial premium of approximately 210%, or $90.52 per share.
• The combined entity will hold over 10,900 Bitcoin, making it a significant player in corporate Bitcoin holdings.
• Strive's management believes their alpha-seeking strategies and capital structure will enable them to outperform Bitcoin over the long run.
• The transaction is expected to drive equity value accretion by growing Bitcoin holdings and Bitcoin per share at an unmatched pace.
• The merger allows for the expansion of Semler Scientific's medical diagnostics business into a robust preventative care and wellness platform.
• The combined company aims to operate with a preferred equity-only leverage model, avoiding debt maturity risks associated with traditional leveraged Bitcoin strategies.

Negatives

• Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction will cause dilution.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• There is a possibility that the anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The combined company intends to become the fastest-growing corporate Bitcoin holder, aiming to operate with a preferred equity-only leverage model to mitigate debt maturity risks. It plans to explore monetizing or distributing Semler Scientific's diagnostics business at a future date, with a new management team and an expanded focus on preventative diagnostics. The strategy is to increase Bitcoin per share to outperform Bitcoin over the long run and drive equity value accretion.

Management Comments

• Matt Cole, Chairman & CEO of Strive, stated, "This merger cements Strive's position as a top Bitcoin treasury company, and we believe our alpha-seeking strategies and capital structure position us to outperform Bitcoin over the long run. This transaction showcases how we can grow Bitcoin holdings and Bitcoin per share at an unmatched pace in the industry to drive equity value accretion."
• Eric Semler, Executive Chairman of Semler Scientific, commented, "We believe this merger creates significant value for our stockholders by delivering a substantial premium and direct participation in one of the most innovative Bitcoin strategies in the public markets. Just as importantly, this merger can drive shareholder value by expanding our medical diagnostics business into a robust preventative care and wellness platform focused on early detection of chronic disease. This dual-pronged strategy fuels both financial strength and mission-driven growth opportunities for our stakeholders."

Industry Context

This merger signifies a notable consolidation within the emerging 'Bitcoin treasury company' sector, where companies strategically hold Bitcoin as a primary reserve asset. By combining Strive's asset management expertise and existing Bitcoin holdings with Semler Scientific's Bitcoin treasury strategy and profitable diagnostics business, the new entity aims to create a diversified model. The move also highlights a trend of companies integrating digital asset strategies with traditional business operations, while the intention to expand into preventative diagnostics aligns with broader healthcare trends focusing on early detection and wellness.

Comparison to Industry Standards

• The combined company's projected holding of over 10,900 Bitcoin positions it among the largest publicly traded corporate Bitcoin holders, comparable to companies like MicroStrategy, which pioneered the corporate Bitcoin treasury strategy.
• The stated goal of becoming the 'fastest growing corporate Bitcoin holder' sets an aggressive benchmark against other companies adopting similar treasury strategies.
• The preferred equity-only leverage model is a distinct approach compared to traditional leveraged Bitcoin strategies, which often involve debt, aiming to mitigate debt maturity risks.
• The 210% premium offered to Semler Scientific shareholders is a significant valuation, indicating strong confidence in the strategic value and future prospects of the combined entity, potentially setting a high bar for future M&A in this niche.
• The dual strategy of Bitcoin accumulation and expansion in preventative diagnostics differentiates the combined company from pure-play Bitcoin treasury companies or traditional medical device firms, creating a unique hybrid model.

Management Changes

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Stakeholder Impact

• Shareholders of Semler Scientific will receive a significant premium and direct participation in Strive's Bitcoin strategy.
• Shareholders of Strive will experience dilution due to the issuance of new shares but are expected to benefit from increased Bitcoin holdings and strategic growth.
• Customers and employees of both companies may experience changes to business or employee relationships, which could be adverse.
• The combined company's dual strategy aims to fuel financial strength and mission-driven growth opportunities for all stakeholders.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• The closing of the transaction is subject to the satisfaction of customary closing conditions.
• The combined company intends to explore monetizing or distributing Semler Scientific's diagnostics business at a future date.

Key Dates

Recommendation

The merger creates a significantly larger entity with a substantial Bitcoin treasury, positioning it as a leader in the corporate Bitcoin space. The 210% premium for Semler Scientific shareholders indicates strong valuation and strategic benefits. The dual strategy of aggressive Bitcoin accumulation and expansion in preventative diagnostics offers diversified growth potential. While dilution is a factor, the long-term value accretion from increased Bitcoin per share and a unique capital structure makes this a compelling investment opportunity.

Keywords

Bitcoin treasury, Merger, Acquisition, Semler Scientific, Strive Inc, ASST, SMLR, All-stock transaction, Digital assets, Medical diagnostics, Preventative care, Corporate governance, SEC filing, Form 8-K